- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 126 results
Webinar
Dezember 18, 2025
Drug Compounding Litigation Review: Cases by Drug Compounders vs. FDA and Private Enforcement Cases
Webinar
Dezember 17, 2025
What Healthcare Providers That Sponsor ERISA Plans Need To Know for 2026
Speaking Engagement
Dezember 8, 2025
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Webinar
November 20, 2025
Data Security Incident Response: How to Plan for It, Deal With It and Survive It
Webinar
November 19, 2025
Prescription for Trouble: FDA’s “Crackdown” on Drug Ads
Conference
November 4, 2025
King & Spalding Pharmaceutical University 2025
Webinar
Oktober 28, 2025
International Trade Law in the Food and Beverage Sector
Webinar
Oktober 23, 2025
Interactions with HCPs, Anti-Kickbacks and Transparency
Speaking Engagement
Oktober 22, 2025
Rob DeConti, Nikki Reeves, John Shakow to Speak at the 26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress Conference
Speaking Engagement
Oktober 8, 2025
Nikki Reeves and Gillian Russell to Speak at the Seton Hall Compliance Congress
Speaking Engagement
Oktober 7, 2025
Nikki Reeves to Speak at the AdvaMed Medtech Conference